Pt Taisho Pharmaceutical Indonesia Tbk (Indonesia)

Quote Chart
Quote Summary
Last Price 329,000.00
Volume 0
Turnover n/a
Index Jakarta Composite Index
Market Indonesia Stock Exchange
Ticker SQBI
Market Cap Market Cap 3,049,172,000
52 Week High 338,000.00
52 Week Low 290,000.00
P/E 18.5
EPS 17782.48
Dividend Yield 14000 (December 31, 2013)
Bookvalue 459,352,720
Enterprise Value 2,856,391,874
Quote updated on February 11, 2016
Note: data in IDR Thousands.
Select Items to chart them. 2015 Q3C
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 421,112,104
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Company Description

PT. Taisho Pharmeceutical Indonesia Tbk. (SQBI), formerly PT. Bristol-Myers Squibb Indonesia Tbk., operates in the development, registration, processing, production and selling of chemical, pharmaceutical and health care products. SQBI manufactures vitamins, analgesics, cardiovascular agents, steroids, antifungals, and antibiotics. In the production, company has tablet press machine, comil, bohle mill; water purification, boiler and generator set facilities. SQBI purchases its raw materials from PT. Mead…

Main Products

Chemical, pharmaceutical and health care products.

Contact Information

Legal Address
Wisma Tamara 10th Floor,Jl. Jenderal Sudirman Kav. 24
Jakarta; Jakarta; Map
Postal Code: 12920
Tel: +62-21-520-6727
Fax: +62-21-520-6735

Full name: Pt Taisho Pharmaceutical Indonesia Tbk

Previous name(s): Pt Bristol-Myers Squibb Indonesia Tbk (2002)

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
ISIN Code: ID1000070006
Incorporation Date: 1970

Basic Information
Total Employees:
Outstanding Shares:
: ()
: ()
Financial Auditors:
2014: Exports Thousands
Export connections ('000)

Thailand (74324491000 IDR)
Malaysia (2868053000 IDR)
Singapore (72481262000 IDR)
Key Executives
Ownership Details
Taisho Pharmaceutical Co
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Indonesia

Register Your Interest

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.